Gregory J. Duman
Plus aucun poste en cours
Profil
Gregory J.
Duman is the founder of PRISM Technologies LLC, which was founded in 2004, where he held the title of President from 2011 to 2015.
He also held former positions as President, Chief Financial Officer & Director at Prism Technologies Group, Inc. from 2003 to 2018, Director at Transgenomic, Inc. from 2000 to 2009, Director at Thomas Equipment, Inc. from 2007 to 2008, Chief Financial Officer, Executive VP & Controller at ACI Worldwide, Inc. from 1983 to 2000, and Chief Financial Officer at Artios, Inc. from 2000 to 2001.
He also held the title of Chief Financial Officer at Osiris Corp.
Mr. Duman received his undergraduate degree from the University of Nebraska in 1979.
Anciens postes connus de Gregory J. Duman
| Sociétés | Poste | Fin |
|---|---|---|
PRISM Technologies LLC
 PRISM Technologies LLC Miscellaneous Commercial ServicesCommercial Services Part of Sabre Corp., PRISM Technologies LLC is a company that provides intellectual property licensing, and technology research and development services. The company is based in Omaha, NE. The company was founded by Gregory J. Duman. PRISM Technologies was acquired by Prism Technologies Group, Inc. on March 30, 2015 for $75.15 million. | Fondateur | 01/09/2021 |
| PRISM TECHNOLOGIES GROUP, INC. | President | 09/08/2018 |
Transgenomic, Inc.
 Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Directeur/Membre du Conseil | 20/05/2009 |
| Thomas Equipment, Inc. | Directeur/Membre du Conseil | 29/01/2008 |
Artios, Inc.
 Artios, Inc. Forest ProductsNon-Energy Minerals Artios, Inc. engages in the manufacture of designer box. It offers jewelry boxes and puzzle. The company was founded on June 29, 1993 and is headquartered in Greensboro, NC. | Directeur Financier/CFO | 01/01/2001 |
Formation de Gregory J. Duman
| University of Nebraska | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ACI WORLDWIDE, INC. | Technology Services |
| PRISM TECHNOLOGIES GROUP, INC. | Technology Services |
| OSIRIS CORPORATION | Producer Manufacturing |
| Entreprise privées | 4 |
|---|---|
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |
| Thomas Equipment, Inc. | Producer Manufacturing |
PRISM Technologies LLC
PRISM Technologies LLC Miscellaneous Commercial ServicesCommercial Services Part of Sabre Corp., PRISM Technologies LLC is a company that provides intellectual property licensing, and technology research and development services. The company is based in Omaha, NE. The company was founded by Gregory J. Duman. PRISM Technologies was acquired by Prism Technologies Group, Inc. on March 30, 2015 for $75.15 million. | Commercial Services |
Artios, Inc.
Artios, Inc. Forest ProductsNon-Energy Minerals Artios, Inc. engages in the manufacture of designer box. It offers jewelry boxes and puzzle. The company was founded on June 29, 1993 and is headquartered in Greensboro, NC. | Non-Energy Minerals |
